Centaur Pharmaceuticals Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Investors
  • 2

Centaur Pharmaceuticals General Information

Description

Developer of novel class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases. The company develops such compounds to treat inflammatory diseases such as acute stroke, dementia, rheumatoid arthritis, myocardial ischemia and Parkinson's disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 1220 Memorex Drive
  • Santa Clara, CA 95050
  • United States
+1 (408) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Centaur Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 12-Dec-2002 000.00 Completed Clinical Trials - Phase 3
5. Convertible Debt 09-Jul-2002 00.000 000.00 Completed
4. Later Stage VC 13-Mar-2000 0000 000.00 00000 Completed Generating Revenue
3. Early Stage VC 01-Dec-1994 00.000 000.00 000.00 Completed Product Development
2. Early Stage VC (Series B) 12-Jul-1993 $3.5M $4.5M 000.00 Completed Generating Revenue
1. Angel (individual) 01-Jan-1991 $1M $1M 00.00 Completed Startup
To view Centaur Pharmaceuticals’s complete valuation and funding history, request access »

Centaur Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 2,545,454 $0.001000 $1.38 $1.38 1x $1.38 8.48%
Series A 2,000,000 $0.001000 $0.5 $0.5 1x $0.5 6.67%
To view Centaur Pharmaceuticals’s complete cap table history, request access »

Centaur Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
John Walker Executive Officer & Director
Wood Paul Executive Officer & Director
Brian Underdown Ph.D Director
Riaz Bandali Director
Charles Povey Executive
You’re viewing 5 of 11 executive team members. Get the full list »

Centaur Pharmaceuticals Board Members (1)

Name Representing Role Since
Michael Callaghan Self Board Member 000 0000
To view Centaur Pharmaceuticals’s complete board members history, request access »

Centaur Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000000 0 01-Jan-1999 000000000000000000 Pharmaceuticals 0000000 00000
To view Centaur Pharmaceuticals’s complete acquisitions history, request access »

Centaur Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 000000 0 01-Jan-1999 000000000000000000 Completed
  • 0000000 0000000000
To view Centaur Pharmaceuticals’s complete exits history, request access »